Irving Vidaurre

LHRH antagonist Cetrorelix reduces prostate size and gene expression of proinflammatory cytokines and growth factors in a rat model of benign prostatic hyperplasia

Ferenc G. Rick, Andrew V. Schally, Norman L. Block et al. · The Prostate · 2010 · 83 citations · Full text

Medicine, Endocrinology, Pharmacology +17

Antagonists of growth hormone-releasing hormone (GHRH) reduce prostate size in experimental benign prostatic hyperplasia

Ferenc G. Rick, Andrew V. Schally, Norman L. Block et al. · Proceedings of the National Academy of Sciences · 2011 · 77 citations · Full text

Medicine, Endocrinology, Pharmacology +17

Effects of a growth hormone-releasing hormone antagonist on telomerase activity, oxidative stress, longevity, and aging in mice

William A. Banks, John E. Morley, Susan A. Farr et al. · Proceedings of the National Academy of Sciences · 2010 · 53 citations · Full text

Education, Endocrinology, Pharmacology +17

Beneficial effects of growth hormone-releasing hormone agonists on rat INS-1 cells and on streptozotocin-induced NOD/SCID mice

Xianyang Zhang, Tengjiao Cui, Jinlin He et al. · Proceedings of the National Academy of Sciences · 2015 · 52 citations · Full text

Medicine, Endocrinology, Pharmacology +17

Antagonists of growth hormone-releasing hormone suppress <i>in vivo</i> tumor growth and gene expression in triple negative breast cancers

Roberto Pérez‐Castañeda, Andrew V. Schally, Irving Vidaurre et al. · Oncotarget · 2012 · 47 citations · Full text

Medicine, Endocrinology, Oncology +17